Running, esophageal acid reflux, and atrial fibrillation: A chain of events linked by evidence from separate medical literatures

Medical Hypotheses

Volumn 71, Issue 2, 2008, Pages 178-185

  Swanson, Don R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ESOMEPRAZOLE; PANTOPRAZOLE; PROPAFENONE; PROTON PUMP INHIBITOR;

ACIDITY; AEROBIC EXERCISE; ARTICLE; ATHLETE; CLINICAL TRIAL; COMORBIDITY; DRUG EFFECT; EXERCISE INTENSITY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; PH MEASUREMENT; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; RUNNING;

ATRIAL FIBRILLATION; DATABASES, BIBLIOGRAPHIC; ELECTROCARDIOGRAPHY; ESOPHAGUS; EXERCISE; GASTROESOPHAGEAL REFLUX; HUMANS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; PROTON PUMP INHIBITORS; RUNNING;

ELAGATIS;

EID: 45649083831     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.02.017     Document Type: Article

References (35)

1. Swanson D.R. Atrial fibrillation in athletes: implicit literature- based connections suggest that overtraining and subsequent inflammation may be a contributory mechanism. Med Hypotheses 66 (2006) 1085-1092
2. Swanson D.R., Smalheiser N.R., and Torvik V.I. Ranking indirect connections in literature-based discovery: the role of medical subject headings. J Am Soc Inf Sci Technol 57 11 (2006) 1427-1439
3. Thalmann M., Sodeck G.H., Kavouras S., Matalas A., Skenderi K., and Yannikouris N. Proton pump inhibition prevents gastrointestinal bleeding in marathon runners: a randomized, double blinded, placebo controlled study. Br J Sports Med 40 4 (2006) 359-362
4. Nakamura H., Nakaji G., Shimazu H., et al. Case of paroxysmal atrial fibrillation improved after the administration of proton pump inhibitor for associated reflux esophagitis. Fukuoka Igaku Zasshi 98 6 (2007) 270-276
5. Weigl M., Gschwantler M., Gatterer E., Finsterer J., and Stollberger C. Reflux esophagitis in the pathogenesis of paroxysmal atrial fibrillation: results of a pilot study. South Med J 96 11 (2003) 1128-1132
6. Stollberger C., and Finsterer J. Treatment of esophagitis/vagitis-induced paroxysmal atrial fibrillation by proton-pump inhibitors. J. Gastroenterol 38 11 (2003) 1109
7. Collings K.L., Pierce Pratt F., Rodriguez-Stanley S., Bemben M., and Miner P.B. Esophageal reflux in conditioned runners, cyclists, and weightlifters. Med Sci Sports Exerc 35 5 (2003) 730-735
8. Budzynski J., Klopocka M., Pulkowski G., and Swiatkowski M. Gastroesophageal acid reflux as a causative factor of paroxysmal atrial fibrillation [Polish] [English abstract]. Kardiol Pol 62 1 (2005) 52-54
9. Yazaki E., Shawdon A., Beasley J., and Evans D.F. The effect of different types of exercise on gastro-oesophageal reflux. Aust J Sci Med Sport 28 4 (1996) 93-96
10. Soffer E.E., Wilson J., Duethman G., Launspach J., and Adrian T.E. Effect of graded exercise on esophageal motility and gastroesophageal reflux in nontrained subjects. Dig Dis Sci 39 1 (1994) 193-198
11. Soffer E.E., Merchant R.K., Duethman G., Launspach J., Gisolfi C., and Adrian T.E. Effect of graded exercise on esophageal motility and gastroesophageal reflux in trained athletes. Dig Dis Sci 38 2 (1993) 220-224
12. Kraus B.B., Sinclair J.W., and Castell D.O. Gastroesophageal reflux in runners. Characteristics and treatment. Ann Intern Med 112 6 (1990) 429-433
13. Choi S.C., Choi S.J., Kim J.A., Nah Y.H., and Yazaki E. The role of gastrointestinal endoscopy in long-distance runners with gastrointestinal symptoms. Eur J Gastroenterol Hepatol 13 9 (2001) 1089-1094
14. Choi S.C., Yoo K.H., Kim T.H., Kim S.H., Choi S.J., and Nah Y.H. Effect of graded running on esophageal motility and gastroesophageal reflux in fed volunteers. J Korean Med Sci 16 2 (2001) 183-187
15. Parmelee-Peters K., and Moeller J.L. Gastroesophageal reflux in athletes [Review]. Curr Sports Med Rep 3 2 (2004) 107-111 Apr
16. Jozkow P., Wasko-Czopnik D., Medras M., and Paradowski L. Gastroesophageal reflux disease and physical activity. Sports Med 36 5 (2006) 385-391
17. Pandolfino J.E., Bianchi L.K., Lee T.J., Hirano I., and Kahrilas P.J. Esophagogastric junction morphology predicts susceptibility to exercise-induced reflux. Am J Gastroenterology 99 8 (2004) 1430-1436 Aug
18. Peters H.P., De Kort A.F., Van Krevelen H., et al. The effect of omeprazole on gastro-oesophageal reflux and symptoms during strenuous exercise. Aliment Pharmacol Ther 13 8 (1999) 1015-1022
19. Cuomo R., De Giorgi F., Adinolfi L., et al. Oesophageal acid exposure and altered neurocardiac function in patients with GERD and idiopathic cardiac dysrhythmias. Aliment Pharmacol Ther 24 2 (2006) 361-370
20. Coumel P. Paroxysmal atrial fibrillation: a disorder of autonomic tone?. Eur Heart J 15 Suppl A (1994) 9-16
21. Mont L., Sambola A., Brugada J., et al. Long-lasting sport practice and lone atrial fibrillation. Eur Heart J 23 (2002) 477-482
22. Coumel P. Atrial fibrillation: one more sporting inconvenience? [Editorial]. Eur Heart J 23 (2002) 431-433
23. Gerson L.B., Friday K., and Triadafilopoulos G. Potential relationship between gastroesophageal reflux disease and atrial arrhythmias. J Clin Gastroenterol 40 9 (2006) 828-832
24. Tomita T., Takei M., Saikawa Y., et al. Role of autonomic tone in the initiation and termination of paroxysmal atrial fibrillation in patients without structural heart disease. J Cardiovasc Electrophysiol 14 (2003) 559-564
25. Chen P.S., and Tan A.Y. Autonomic nerve activity and atrial fibrillation [Review]. Heart Rhythm 4 3, Suppl. 1 (2007) S61-S64
26. Euler D.E., and Friedman P.A. Atrial arrhythmia burden as an endpoint in clinical trials: is it the best surrogate? Lessons from a multicenter defibrillator trial. Card Electrophysiol Rev 7 (2003) 355-358
27. Rho R.W., and Page R.L. Asymptomatic atrial fibrillation [Review]. Prog Cardiovasc Dis 48 2 (2005) 79-87
28. Wyse D.G. Anticoagulation in atrial fibrillation. A contemporary viewpoint. Heart Rhythm 4 3 (2007) S34-S39 Mar
29. Capucci A., Santini M., Padeletti L., et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 46 10 (2005) 1913-1920
30. Hohnloser S.H., Capucci A., Fain E., et al. Asymptomatic atrial fibrillation and stroke evaluation in pacemaker patients and the atrial fibrillation reduction atrial pacing trial (ASSERT). Am Heart J 152 3 (2006) 442-447
31. Grassia T. Device of the month. New event monitor accurately assesses atrial fibrillation. Cardiol Today 2007, http://www.cardiologytoday.com downloaded 12/28/97.
32. http://www.medicompinc.com accessed 12/28/97.
33. Johnson D.A., and Fennerty M.B. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology 126 3 (2004) 660-664
34. Chanbers P.W. Lone atrial fibrillation: pathologic or not?. Med Hypotheses 68 (2007) 281-287
35. Schillinger W., Teucher N., Sossala S., Kettlewell S., Werner C., and Raddaz D. Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: evaluation of mechanisms. Circulation 116 1 (2007) 57-66